Sirius Analytical and Paraytec enter into development and technology licensing agreement

Posted: 7 January 2013 | | No comments yet

“We are delighted to begin this strategic partnership with Paraytec…”

Sirius Analytical Logo

Sirius Analytical Instruments Ltd and Paraytec Ltd announce today that they have entered into a development and licensing agreement that will give Sirius Analytical exclusive rights to develop, manufacture and sell ActiPixTM UV area imaging technology in specific fields of use related to applications based upon dissolution from a surface using imaging techniques and the determination of concentration gradients.

Sirius Analytical are the leaders in instrumentation and services for the determination of physicochemical properties. Sirius Analytical’s instrumentation is the most reliable and advanced in the market and is routinely used within the industry for physicochemical property determination. The most recent introduction, the SiriusT3, is a fully automated system for rapid and accurate measurement of physicochemical properties using small, often sub-milligram, quantities of material.

Paraytec Ltd develops and distributes instrumentation for pharmaceutical and biopharmaceutical applications based on its patented ActiPix™ technology, a 2-dimensional platform for ultra-violet (UV) absorbance measurement, using capillaries and flow cells in conjunction with optics and active pixel area sensors.

Brett Hughes, Chief Executive Officer of Sirius Analytical said: “We are delighted to begin this strategic partnership with Paraytec, and to be adding their innovative UV area imaging technology to our capabilities. Understanding dissolution is an essential requirement during the pre-formulation stages of drug development, and the ActiPixTM UV area imaging technology complements our existing capabilities for the determination of solubility and dissolution. Our customers will benefit from this strategic partnership and the use of ActiPix™ technology by gaining visual insight into the dissolution process as it happens for the first time.”

Mark Vaux, Chief Executive Officer of Paraytec said: “This is a key step forward in the development of our company. We look forward to working with Sirius Analytical and incorporating our ActiPix™ technology within further developments for applications based upon dissolution.”

Related people